Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis
Authors:
- Maarten BoersMBMaarten Boers
- for the COBRA Trial GroupFGfor the COBRA Trial Group
- 1 October 2001
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (10) , 2242-2246
Abstract
Several factors predict joint damage in early rheumatoid arthritis (RA). In the context of a trial in early RA, we studied the relationship between clinical signs in individual joints and their propensity to develop progressive damage. The COBRA (Combinatietherapie Bij Reumatoide Artritis) multicenter trial compared the efficacy of prednisolone, methotrexate, and sulfasalazine against sulfasalazine alone in 155 patients with early RA. Two blinded observers interpreted radiographs in sequence (using the Sharp/Van der Heijde scoring system); in each center, one blinded observer performed clinical assessments every 3 months. The current analysis is based on clinical and radiologic data of the individual metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints of 135 patients. Conditional stepwise logistic regression analyzed the relationship between damage (progression) and clinical signs at baseline and followup for each of these joints individually in each patient. Combination therapy strongly retarded the progression of damage. Progression was stronger in patients with rheumatoid factor, HLA–DR4, and high levels of disease activity at baseline. At baseline, 6% of the MCP and PIP joints showed damage; after 1 year, disease had progressed in 10% of these joints. Baseline damage, swelling, or pain in a joint independently and strongly predicted the progression of damage in that joint (P < 0.001). Each additional point in the swelling score (range 0–2) tripled the risk for subsequent progression. Each additional point on the Sharp scale (range 0–8 per joint) and each additional point on the pain scale (range 0–3) doubled the risk. The mean pain and swelling scores over the year were even stronger predictors of damage. Local expression of early RA disease activity, both at baseline and at 1-year followup, is strongly related to progression of damage in the individual joint.Keywords
This publication has 12 references indexed in Scilit:
- Prognostic factors in early rheumatoid arthritisRheumatology, 2000
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisThe Lancet, 1997
- The relationship between synovitis and erosions in rheumatoid arthritisRheumatology, 1997
- 2 Can we predict aggressive disease?Bailliere's Clinical Rheumatology, 1997
- EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITISThe Lancet, 1989
- Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.Annals of the Rheumatic Diseases, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Relationship between clinical synovitis and radiological destruction, in rheumatoid arthritisClinical Rheumatology, 1983
- Clinical Synovitis and Radiological Lesions in Rheumatoid Arthritis: A Prospective Study of 25 Patients during Treatment with Remission-inducing DrugsScandinavian Journal of Rheumatology, 1983
- A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritisArthritis & Rheumatism, 1965